1-Acetoxy-2-bromoethane → 2-(2-chloro-6-morpholino-9H-purin-9-yl)ethyl acetate
Reaction equation
[Cl:1][C:2]1[N:10]=[C:9]2[C:5]([N:6]=[CH:7][NH:8]2)=[C:4]([N:11]2[CH2:16][CH2:15][O:14][CH2:13][CH2:12]2)[N:3]=1.[C:17]([O:20][CH2:21][CH2:22]Br)(=[O:19])[CH3:18]>>[C:17]([O:20][CH2:21][CH2:22][N:8]1[CH:7]=[N:6][C:5]2[C:9]1=[N:10][C:2]([Cl:1])=[N:3][C:4]=2[N:11]1[CH2:12][CH2:13][O:14][CH2:15][CH2:16]1)(=[O:19])[CH3:18]Participants
3
Procedure
4-(2-Chloro-9H-purin-6-yl)morpholine (75 mg) was reacted with 2-bromoethyl acetate via General Procedure C to give 2-(2-chloro-6-morpholino-9H-purin-9-yl)ethyl acetate which was reacted with 150 mg tert-butyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl carbonate via General Procedure A and purified via reverse phase HPLC to give 59.4 mg of 144 as a white solid. MS (Q1) 342.2 (M)+
Sources & evidence
- ORD record
- ord-41e4cb4393244dbf897c197df09dfde5
- Source dataset
- uspto-grants-2013_05
- Patent number
- US08445487B2
Reaction notes
Loading…